Related references
Note: Only part of the references are listed.Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL
Prediman K. Shah
CURRENT OPINION IN CARDIOLOGY (2010)
The protein cargo of HDL: Implications for vascular wall biology and therapeutics
Jay W. Heinecke
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
RVX-208 A Small Molecule That Increases Apolipoprotein A-I and High-Density Lipoprotein Cholesterol In Vitro and In Vivo
Dana Bailey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Yin and Yang of Cholesteryl Ester Transfer Protein in Cardiovascular Disease
Prediman K. Shah
CIRCULATION (2009)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins - An idea whose time for testing is coming, Part II
PK Shah et al.
CIRCULATION (2001)
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins - An idea whose time for testing is coming, Part I
PK Shah et al.
CIRCULATION (2001)
Share Paper
